FDA Seeks OMB Nod for Device Accessory Info Gathering
Published Date: 9/3/2025
Notice
Summary
The FDA wants to collect info about medical device accessories and has asked the Office of Management and Budget to review this plan. This affects companies making or selling these accessories, who might need to share more details soon. The goal is to keep things safe without causing extra hassle or costs, and the review is happening now to keep everything on track.
Analyzed Economic Effects
1 provisions identified: 0 benefits, 1 costs, 0 mixed.
FDA Seeks OMB Clearance for Accessory Data
If you make or sell medical device accessories, you may need to provide additional information soon because the FDA submitted a proposed collection of information to the Office of Management and Budget for review under the Paperwork Reduction Act of 1995. The agency says the goal is to keep accessories safe while avoiding extra hassle or costs for companies.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2026-16939, GNT USA, LLC.; Filing of Color Additive Petition
The Food and Drug Administration (FDA or we) is announcing that we have filed a petition, submitted by GNT USA, LLC., c/o Exponent, Inc., proposing that we amend our color additive regulations to provide for the safe use of safflower (Carthamus tinctorius L.) extract as a color additive in various foods at levels consistent with good manufacturing practices.
2026-16942, Food Additives Permitted in Feed and Drinking Water of Animals; Chromium DL-methionine Chelate
The Food and Drug Administration (FDA, we, or the Agency) is amending the regulations for food additives permitted in feed and drinking water of animals to provide for the safe use of chromium DL- methionine chelate as a nutritional source of chromium in cattle feed. This action is in response to a food additive petition filed by Zinpro Corp.
2026-16944, Gardenia Blue Interest Group; Filing of Color Additive Petition
The Food and Drug Administration (FDA or we) is announcing that we have filed a petition, submitted by Gardenia Blue Interest Group (GBIG or petitioner), c/o Exponent, Inc., proposing that we amend our color additive regulations to expand the safe use of gardenia (genipin) blue in various foods at levels consistent with good manufacturing practice. The petition also proposes to lower the specification for arsenic in gardenia (genipin) blue.
Previous / Next Documents
Previous: 2025-16852, General Hospital and Personal Use Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments
The FDA is hosting a public meeting with experts to talk about medical devices, especially those used in pandemic preparedness. They want your thoughts too, so they’re opening a public comment period. This affects device makers, healthcare workers, and anyone interested in safer, smarter health tools, with important discussions happening soon and no cost to join in.
Next: 2025-16854, Agency Information Collection Activities; Extension of a Currently Approved Collection: Immigration Bond
ICE is asking to keep collecting info about immigration bonds, which help people stay out of jail while their case is decided. This update doesn’t change the rules or costs but makes sure the paperwork stays official and easy to handle. If you’re involved in immigration bonds, this means the process will keep running smoothly without surprises.